Liu, Y., & Jeng, W. (2022). Editorial: Is functional cure the only holy grail for treatment discontinuation in patients with HBeAg‐negative chronic hepatitis B? Alimentary Pharmacology & Therapeutics, 56(3), 544. https://doi.org/10.1111/apt.17067
Chicago Style (17th ed.) CitationLiu, Yen‐Chun, and Wen‐Juei Jeng. "Editorial: Is Functional Cure the Only Holy Grail for Treatment Discontinuation in Patients with HBeAg‐negative Chronic Hepatitis B?" Alimentary Pharmacology & Therapeutics 56, no. 3 (2022): 544. https://doi.org/10.1111/apt.17067.
MLA (9th ed.) CitationLiu, Yen‐Chun, and Wen‐Juei Jeng. "Editorial: Is Functional Cure the Only Holy Grail for Treatment Discontinuation in Patients with HBeAg‐negative Chronic Hepatitis B?" Alimentary Pharmacology & Therapeutics, vol. 56, no. 3, 2022, p. 544, https://doi.org/10.1111/apt.17067.